Skip to content

IR Zen

Asia News & Headlines, Press Releases & Events

  • Home
  • SeaPRwire
  • EQS Newswire
  • ACN Newswire
  • JCN Newswire
  • Contact

Tag: 和铂医药-b(02142.hk):营收大增11.5倍,多管线获重大突破,显现巨大创新力

Posted on September 5, 2022 by: eqs

和铂医药-B(02142.HK):营收大增11.5倍,多管线获重大突破,显现巨大创新力

       

EQS 新闻 via SEAPRWire.com / 2022-09-05 / 10:27 UTC+8 和铂医药-B(02142.HK):营收大增11.5倍,多管线获重大突破,显现巨大创新力   来源:格隆汇   8月31日,港股医药公司和…

More ...

网站导航

  • 网站首页
  • SeaPRwire
  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • 财经新闻
  • 商业新闻
  • 国际新闻
  • 联络我们
  • 关于我们
  • RSS订阅

最新资讯

  • Open Doors to the Asian Market: Seoul Bio Hub-Celltrion Launches ‘Global Open Innovation’ for U.S. Startups
  • Anti-MTBR (microtubule binding region) Tau Antibody Etalanetug Granted FDA Fast Track Designation
  • BestStock.ai unveils autonomous AI for real-time market analysis and predictive modeling
  • Honda Announces New Electric Motorcycle “Honda WN7” in Europe
  • 东吴水泥苏州国资入主 绘就港苏协同新蓝图
  • 教皇利奥十四世告诉美国大使,他在查理·柯克遇刺后为他及其家人祈祷 “`
  • sureWin Partners with Daesung and the Black Eyed Peas in Landmark Month for Asian Music
  • Klarna对金融科技行业的影响
  • Ultraman Card Game Original Illustration of “Alien Metron” By Manga Artist Yukinobu Tatsu to be Included in the Upcoming Booster Pack Release
  • IFBH牵手中粮名庄荟 强强联合夯实长远发展根基
  • Professor Lin Xiang Xiong Hosts Landmark Art Exhibition and Peace Prize Ceremony in Paris
  • Opendoor新CEO:一个转折点?
  • 7亿美元加注协鑫科技 发力技术迭代赋能落后产能出清
  • Karbon-X Corp. Files Year-End Financial Results
  • EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • HKBrowse
  • AccessTH
  • AseanTrend
Copyright © 2025 IRZen.com